A glutathione injection question needs an exact formulation and route. Evidence from an oral supplement or topical lotion addresses that intervention, rather than establishing an injectable preparation or schedule.
Which form of glutathione?
Reduced glutathione (GSH) and oxidized glutathione (GSSG) are distinct forms. The compound name, supplied form, amount and administration route should remain attached to any study result.
Three studies, three routes
The route changes the question a study can answer. Oral, topical and intravenous results cannot be read as evidence for the other formulations.
| Primary study | Intervention and comparison | What it measured | Result and limit |
|---|---|---|---|
| 2017 randomized oral study | Reduced glutathione (GSH) or oxidized glutathione (GSSG), 250 mg/day by mouth for 12 weeks, versus placebo | Skin melanin index, wrinkles and other skin properties | Some measures favored glutathione at selected sites. This was an oral study, not an injection study. |
| 2014 randomized topical study | 2% topical GSSG lotion on one side of the face and placebo on the other, twice daily for 10 weeks, in 30 healthy women | Melanin index, moisture, wrinkles, smoothness and elasticity | Melanin index favored GSSG during the study. The intervention was topical lotion. |
| 2016 intravenous placebo-controlled study | Enrolled 50 women; 32 completed. The reported injection combined 1,200 mg glutathione with vitamin C and other ingredients, twice weekly for 6 weeks, versus saline | Taylor hyperpigmentation scale, measured through 6 months after treatment | Among completers, the study reported its significant-improvement criterion in 6/16 participants in the glutathione group and 3/16 controls; the between-group comparison was p=0.054. At 6 months, one treated participant retained improvement. The reported comparison does not establish a durable benefit. |
The intravenous trial is a relevant route-specific data point, but its completer-only results, small groups, multi-ingredient injection and loss of the reported effect over follow-up limit what it can establish. It does not specify a general injectable formulation or regimen.
Amount, volume and concentration
The relationship is concentration = total amount divided by final solution volume. Milligrams describe amount, milliliters describe volume, and mg/mL describes concentration. A stated amount alone cannot establish a preparation specification.
From the FormBlends catalog
Glutathione Injectable
Injectable antioxidant support for cellular wellness · From $119/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Glutathione Injectable →What a formulation record adds
The formulation record identifies the supplied material, solvent specification, final volume, container and storage conditions. A study of skin outcomes does not establish these preparation details. Likewise, a purity figure does not supply a storage-period validation.
Compare claims without changing the intervention
When a page says that "a glutathione study showed results," locate the exact form, route, comparison group, observation period and endpoint. Those fields explain which question the study answered. A biochemical mechanism and a clinical outcome are different kinds of evidence.
FAQ
Can an oral study establish an injection schedule?
No. Its intervention and exposure are different.
Does a vial amount choose the solvent volume?
No. The total amount is one input, while the preparation specification identifies the intended solution.
Does a before-and-after image establish the effect of glutathione alone?
An image does not by itself identify a comparison group, other interventions, lighting conditions or the time interval.
Related research guide
NAD+ formulations and human study methods
Risks, Warnings, and What the FDA Actually Said
The FDA glutathione alerts cited here concern ingredient quality in sterile injectable compounding. FDA's June 2019 alert described excess endotoxin in dietary supplement-grade glutathione used in compounded IV products; its August 2026 update revisited the use of dietary supplement-grade glutathione for injectables. These are not a 2020 FDA communication about skin-lightening efficacy. FDA 2019 alert; FDA August 2026 update.
Additional risk considerations:
- Bronchospasm: Case reports exist of bronchospasm with inhaled glutathione; IV risk appears low but is not zero in atopic individuals.
- Thyroid interference: Very high chronic doses have been speculated to reduce thyroid hormone levels based on limited case data. No well-powered trial has confirmed this; it remains a low-frequency concern.
- Antioxidant blunting of training adaptation: A well-established concern with high-dose antioxidants generally (Ristow et al., 2009, PNAS) is that quenching ROS blunts mitochondrial biogenesis signaling. This applies to GSH in principle though has not been tested directly for injectable GSH in athletes.
- Sterile technique failure: The most immediate practical risk. Any failure of aseptic technique during reconstitution or injection can cause local abscess or systemic sepsis.
Disclaimers
Platform: FormBlends is an informational platform. Nothing on this page constitutes medical advice, diagnosis, or treatment. Consult a licensed healthcare provider before initiating any injectable protocol.
Research Compound / Compounded Medication: Glutathione is not FDA-approved as a finished drug product for most indications discussed here. Where obtained through compounding pharmacies, it requires a valid prescription from a licensed prescriber. Research-grade vials are not intended for human use.
Results: Individual outcomes vary. The evidence summaries on this page reflect population-level clinical trial data and do not guarantee any specific result for any individual user.
Never shake.
Ready when you are
Glutathione Injectable
Injectable antioxidant support for cellular wellness · From $119/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Glutathione Injectable →